Blood cancers

Infectious complications halve survival rates despite advances in CLL therapy

Infectious complications continue to have a major impact on survival in patients with chronic lymphocytic leukaemia despite advances in immune therapy, haematologists  say. Overall survival rates among CLL patients with infection are approximately half those of patients with no infection, according to a review of long term outcomes of patients treated by clinicians from the ...

Already a member?

Login to keep reading.

© 2021 the limbic